Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

IDEATE: IPILIMUMAB DRUG EVALUATION

Class 44Status: Registered
Application Number2003670
Trademark Status
Registered
Trademark Class44
Application Date2010-08-04
Proprietor Name(1) BRISTOL-MYERS SQUIBB COMPANY.Trading As : BRISTOL-MYERS SQUIBB COMPANY.Body Incorporate
Appropriate OfficeDELHI
StateSTATE NOT SPECIFIED
Trademark TypeWORD
User DetailsProposed to be used
Agent NameRAHUL CHAUDHRY & PARTNERS[24020]
Agent AddressRCY HOUSE, C-235, DEFENCE COLONY, NEW DELHI-110024
Goods And Services Details[CLASS : 44] MEDICAL AND SCIENTIFIC RESEARCH, NAMELY, CONDUCTING CLINICAL TRIALS RELATING TO PHARMACEUTICAL PREPARATIONS FOR HUMAN USE IN CLASS 42..

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
IDEATE: IPILIMUMAB DRUG EVALUATION44Registered

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about IDEATE: IPILIMUMAB DRUG EVALUATION.

The current status of trademark application 2003670 for IDEATE: IPILIMUMAB DRUG EVALUATION is Registered.
IDEATE: IPILIMUMAB DRUG EVALUATION is registered under trademark class 44.
The proprietor of IDEATE: IPILIMUMAB DRUG EVALUATION is (1) BRISTOL-MYERS SQUIBB COMPANY.Trading As : BRISTOL-MYERS SQUIBB COMPANY.Body Incorporate.
Trademark application 2003670 for IDEATE: IPILIMUMAB DRUG EVALUATION was filed on 2010-08-04.